Chemotherapy can assist immunotherapy by downregulating PD-L2 expression on DCs and tumour cells, inducing APCs to mature, restoring tumour visibility, and upregulating MHC-I expression.89 Pemetrexed, carboplatin chemotherapy and pembrolizumab are approved therapies. This evidence concerns the gene PDCD1LG2 and neoplasm.